The Global Therapeutic Antibody Market Research Report 2024

The global therapeutic antibody market is anticipated to witness significant growth, as indicated by the latest report from Research and Markets titled “Global Therapeutic Antibody Market (2023 Edition): Analysis By Antibody Type, Source, Application, By Region, By Country: Market Insights and Forecast (2019-2029).” Here’s a breakdown of the key findings and insights provided in the report:

1. Market Growth: The global therapeutic antibody market is projected to reach USD 428.20 billion by 2029, witnessing substantial expansion from USD 211.23 billion in 2022. Over the forecast period of 2024-2029, the market is expected to grow at a Compound Annual Growth Rate (CAGR) of 11.21%.
2. Market Analysis: The report offers a detailed analysis of various segments within the global therapeutic antibody market. It covers different antibody types such as Monoclonal, Bispecific, Antibody Drug Conjugates, and Others, along with their respective market sizes and growth trajectories. Additionally, it examines the market based on the antibody source (Fully human, Humanized, Others) and application areas (Oncology, Autoimmune, Infectious disease, Others).
3. Regional Insights: The study provides comprehensive insights into the market across different regions, including the Americas, Europe, APAC, and the Middle East Africa. It further explores the market landscape in 10 key countries, including the United States, Canada, United Kingdom, Germany, France, Spain, China, Japan, South Korea, and India.
4. Market Dynamics: The report assesses growth drivers, restraints, supply and demand risks, and other pertinent factors influencing market dynamics. It emphasizes the increasing prevalence of chronic diseases, advancements in biotechnology, and the potential for personalized medicine as key drivers for market expansion.
5. COVID-19 Impact: The report underscores the importance of therapeutic antibodies in managing infectious diseases, particularly in the context of the COVID-19 pandemic. It highlights the expedited development, clinical trials, and regulatory approval processes for antibody-based treatments, showcasing the agility of the industry and regulatory agencies in responding to emerging health crises.
6. Technological Advancements: Researchers continue to engineer antibodies with improved specificity and affinity for their target antigens. This includes the development of novel antibody formats such as nanobodies, bispecific antibodies, and multispecific antibodies, expanding therapeutic capabilities and applications.
7. Market Scope: The report provides an in-depth analysis of the therapeutic antibody market by value (USD Billion), product type, source, and application. It also presents insights through frameworks such as SWOT analysis and Porter’s Five Forces Analysis, highlighting opportunities, trends, drivers, and challenges within the industry.
8. Competitive Landscape: The report includes a competitive landscape analysis, positioning major market players such as F. Hoffmann-La Roche AG, Bristol-Myers Squibb Co., AbbVie Inc., Merck & Co., Inc., Johnson & Johnson, Novartis, Regeneron Pharmaceuticals, Takeda Pharmaceuticals, Amgen, Inc., and Eli Lilly and Company. It tracks competitive developments, strategies, mergers and acquisitions, and new product developments.

Overall, the report presents a comprehensive outlook on the global therapeutic antibody market, providing valuable insights for stakeholders, investors, and market participants to make informed decisions and capitalize on emerging opportunities in the sector.

Related posts:

The Global Antibiotic Drugs Market Report 2024-2029: A $50.41 Billion Industry in 2022 Global IV & Oral Iron Drugs Market Report 2024: Market to Reach $16.43 Billion by 2029 Global CD3 Antibodies Market Research Report 2023-2028 Highlights Steady Growth and Clinical Development Focus on Cancer Indications Global Acute Myeloid Leukemia (AML) Therapeutics Market Projected to Reach $1.6 Billion by 2030